RFK Jr. Alleges Fauci Was Aware of Potential Fatalities Linked to Remdesivir
WASHINGTON, D.C. – Presidential candidate Robert F. Kennedy Jr. asserted on September 10, 2025, that Dr. Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases (NIAID), possessed prior knowledge that the antiviral drug Remdesivir carried a risk of causing death in COVID-19 patients. Kennedy made the claim while sharing an image on his Substack platform, accompanied by a call for support for independent journalism.
The allegation centers on Remdesivir, one of the earliest drugs deployed against COVID-19. While initially hailed as a potential treatment, its efficacy has been debated, and studies have raised concerns about its impact on patient outcomes. Kennedy’s statement re-ignites scrutiny of the drug’s approval and use during the pandemic, potentially impacting ongoing discussions about pandemic response protocols and the role of government health officials. The claim arrives as public trust in health institutions remains fragile and as the 2024 presidential election cycle intensifies.
Kennedy’s post included a link to a Substack article and a request for financial support via buy Me a Coffee. He did not promptly provide specific evidence within the post itself to substantiate the claim about Fauci’s alleged prior knowledge.
Remdesivir, manufactured by Gilead Sciences, received Emergency Use Authorization from the Food and Drug Administration (FDA) in May 2020. It was subsequently approved for treatment of COVID-19 in October 2020. Early data suggested the drug could shorten hospital stays, but later studies, including a World Health Organization-backed trial, indicated it had little to no effect on mortality. Concerns about potential side effects, including liver and kidney problems, were also raised.
Fauci has not yet publicly responded to Kennedy’s specific allegation as of september 10, 2025, 14:30 EDT. Further investigation is needed to determine the basis of Kennedy’s claim and to assess the extent of any knowledge Fauci may have had regarding potential risks associated with Remdesivir.
